In today’s issue: Our in-depth WP Intelligence report on Medicaid’s new approach to innovative yet pricey drugs. Botox ...

Benchmark nears record, ANZ beats forecasts; AMP sinks on profit fall, margins pressure; Origin upgrades outlook; Senator ...

Benchmark eyes best close on record, ANZ beats forecasts; AMP sinks on profit fall, margins pressure; Origin upgrades outlook ...

By Rajasik Mukherjee Feb 10 (Reuters) - Australia's CSL tapped insider Gordon Naylor as interim CEO on Tuesday after announcing the retirement of current chief Paul McKenzie, as the biotech firm seeks ...

Florida-based Jabil Inc. (JBL) operates as a key manufacturing and engineering partner to many of the world’s leading brands, ...

It’s still early in the earnings season, but already we have two chief executive beheadings, while one of the big four banks ...

Amgen today announced the European Commission (EC) has approved UPLIZNA® (inebilizumab) as an add-on treatment to standard therapy for adults living with generalized myasthenia gravis (gMG) who are ...

For generations we have defined economic success by what a country makes - cars, ships, computers, weapons. But that paradigm is shifting as more of our activity moves into the digital sphere. For ...

An extended yen rally may signal a shift in investor sentiment as bond markets remain steady after Japan’s election.

Managing chronic disease often involves addressing one problem at a time: pain is managed, inflammation is suppressed, organ ...

CSL’s share price has now halved in 18 months, shredding more than $70 billion of shareholder wealth after the latest ...

Naomi Hoyer, DVM, DAVDC, an associate professor of dentistry and oral surgery at Colorado State University in Fort Collins, ...